Published in J Urol on March 01, 1997
Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction. World J Urol (2009) 0.95
Place of overactive bladder in male lower urinary tract symptoms. World J Urol (2009) 0.93
Correlation of male overactive bladder with intravesical prostatic protrusion. Korean J Urol (2010) 0.90
Retracted Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms. BMC Surg (2012) 0.90
Overactive bladder in males. Ther Adv Urol (2009) 0.88
Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study. Korean J Urol (2013) 0.87
First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment? World J Urol (2006) 0.85
Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia. Rev Urol (2005) 0.85
Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol (2016) 0.84
Does anticholinergic medication have a role in treating men with overactive bladder and benign prostatic hyperplasia? Naunyn Schmiedebergs Arch Pharmacol (2008) 0.81
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxin. World J Urol (2006) 0.80
Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study. World J Urol (2011) 0.78
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia. Drug Des Devel Ther (2015) 0.77
New therapeutic strategies for the treatment of male lower urinary tract symptoms. Res Rep Urol (2016) 0.77
A Survey on Lower Urinary Tract Symptoms (LUTS) Among patients with Benign Prostatic Hyperplasia (BPH) in Hospital Universiti Sains Malaysia (HUSM). Malays J Med Sci (2007) 0.75
Lower urinary tract symptoms smorgasbord: international fare. J Urol (1997) 0.75
Predictors of urgency improvement after Holmium laser enucleation of the prostate in men with benign prostatic hyperplasia. Investig Clin Urol (2016) 0.75
Men's preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment. Patient Prefer Adherence (2016) 0.75
New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives. BMC Urol (2016) 0.75
Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats. World J Mens Health (2016) 0.75
Effect of morphine on lower urinary tract discomfort after transurethral resection of prostate under general anesthesia: a randomised clinical study. J Anesth (2013) 0.75
Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia. J Huazhong Univ Sci Technolog Med Sci (2017) 0.75
Prevalence and burden of overactive bladder in the United States. World J Urol (2002) 7.33
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int (2001) 5.10
Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. BMJ (1998) 4.79
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn (2010) 4.48
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21
The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl (1988) 3.12
Antioxidants in chocolate. Lancet (1996) 3.02
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol (2004) 2.73
Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res (2002) 2.66
New words for old: lower urinary tract symptoms for "prostatism". BMJ (1994) 2.60
The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol (1996) 2.50
Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet (1979) 2.48
Implantation of a foetal thymus, restoring immunological competence in a patient with thymic aplasia (Digeorge's syndrome). Lancet (1968) 2.40
Five-year analysis of protective isolation. Lancet (1971) 2.31
Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol (2005) 2.31
Why don't patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee. J Epidemiol Community Health (2001) 2.26
Screening for prostate cancer in the UK. Seems to be creeping in by the back door. BMJ (2001) 2.22
A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol (1998) 2.20
Definition of overactive bladder and epidemiology of urinary incontinence. Urology (1997) 2.14
Overactive bladder significantly affects quality of life. Am J Manag Care (2000) 2.13
Automated prostate volume determination with ultrasonographic imaging. J Urol (1995) 2.13
Ethnicity and health: a research review. Soc Sci Med (1984) 2.12
The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Is the bladder a reliable witness for predicting detrusor overactivity? J Urol (2006) 1.95
Encephalopathy in acute leukaemia associated with methotrexate therapy. Arch Dis Child (1972) 1.93
The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol (1996) 1.89
Reporting clinical outcomes of breast reconstruction: a systematic review. J Natl Cancer Inst (2010) 1.88
The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct (2001) 1.82
Referral patterns and diagnoses in women attending a urodynamic unit. BMJ (1992) 1.81
Changes in metabolism of collagen in genitourinary prolapse. Lancet (1996) 1.80
Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer (2010) 1.79
The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Br J Obstet Gynaecol (1999) 1.79
Randomised trial of effectiveness of second eye cataract surgery. Lancet (1998) 1.73
Questionnaires to assess urinary and anal incontinence: review and recommendations. J Urol (2007) 1.67
Development of a questionnaire for measurement of vision-related quality of life. Ophthalmic Epidemiol (1998) 1.65
The nutcracker syndrome: new aspects of pathophysiology, diagnosis and treatment. J Urol (1991) 1.63
A three month double-blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction. Br J Urol (1994) 1.62
Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study. Br J Cancer (2011) 1.62
A practical clinical method for contour determination in ultrasonographic prostate images. Ultrasound Med Biol (1994) 1.60
Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther (2011) 1.59
A nomogram to classify men with lower urinary tract symptoms using urine flow and noninvasive measurement of bladder pressure. J Urol (2005) 1.55
Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet (2000) 1.54
Long-term followup of 158 young adults surgically treated for vesicoureteral reflux in childhood: the ongoing risk of urinary tract infections. J Urol (2002) 1.51
Rhabdomyosarcoma of the bladder, prostate or vagina: the role of surgery. BJU Int (2004) 1.50
Mainz Pouch II technique: 10 years' experience. BJU Int (2004) 1.50
Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia. Br Med J (1973) 1.50
Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int (2000) 1.46
Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol (1996) 1.46
Urethral recurrence of transitional cell carcinoma in a female patient after cystectomy and orthotopic ileal neobladder. J Urol (2000) 1.45
[Prevalence of lower urinary tract symptoms in men and its influence on their quality of life: Boxmeer Study]. Ned Tijdschr Geneeskd (2000) 1.45
Association of adiponectin multimers with Barrett's oesophagus. Gut (2009) 1.43
Desmopressin in the treatment of nocturnal polyuria in the male. BJU Int (1999) 1.43
Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors. Ann Intern Med (1986) 1.42
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med (2016) 1.41
Screening for renal cell carcinoma using ultrasonography: a feasibility study. BJU Int (2003) 1.41
Quality-of-life assessment in patients after laser prostatectomy. Br J Urol (1997) 1.41
Personal computers and urological research. Br J Urol (1992) 1.40
Evaluation and treatment of lower urinary tract symptoms in older men. J Urol (2009) 1.40
Unmet need for joint replacement: a qualitative investigation of barriers to treatment among individuals with severe pain and disability of the hip and knee. Rheumatology (Oxford) (2003) 1.40
L-asparaginase in treatment of acute leukaemia and lymphosarcoma. Br Med J (1970) 1.39
Scoring the short form ICSmaleSF questionnaire. International Continence Society. J Urol (2000) 1.39
Prostate cancer: to screen or not to screen? Lancet Oncol (2000) 1.36
Recovery of human foetal liver cells after storage in liquid nitrogen. J Clin Pathol (1968) 1.34
Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int (2002) 1.33
Risk factors for acute graft-versus-host disease. Br J Haematol (1987) 1.33
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology (1997) 1.32
Tubeless percutaneous nephrolithotomy--the new standard of care? J Urol (2010) 1.31
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31
Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol (2004) 1.29
The effect of fluid intake on urinary symptoms in women. J Urol (2005) 1.28
Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate (1998) 1.27
A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study. J Urol (2000) 1.27
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
The Abrams-Griffiths nomogram. World J Urol (1995) 1.25
Outcomes of total knee replacement: a qualitative study. Rheumatology (Oxford) (2005) 1.23
Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess (2010) 1.22
In support of pressure-flow studies for evaluating men with lower urinary tract symptoms. Urology (1994) 1.22
Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Obstet Gynaecol (1997) 1.22
Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate. J Clin Pathol (2000) 1.21
Urinary symptoms and incontinence in women: relationships between occurrence, age, and perceived impact. Br J Gen Pract (1999) 1.20
The correlation between bladder outlet obstruction and lower urinary tract symptoms as measured by the international prostate symptom score. J Urol (1996) 1.19
The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol (1998) 1.19
Development and psychometric evaluation of the ICIQ Vaginal Symptoms Questionnaire: the ICIQ-VS. BJOG (2006) 1.18
Further observations on patients with a chromosomal abnormality associated with polycythaemia vera. Br J Haematol (1968) 1.18
Hereditary lymphopenic agammaglobulinemia associated with a distinctive form of short-limbed dwarfism and ectodermal dysplasia. J Pediatr (1969) 1.17
The endoscopic approach to the distal ureter in nephroureterectomy for upper urinary tract tumor. J Urol (2001) 1.15
Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol (2008) 1.15
Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol (1998) 1.15
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15